XASX
TD1
Market cap32kUSD
Nov 11, Last price
0.00AUD
Name
Tali Digital Ltd
Chart & Performance
P/E
—
P/S
39.40
EPS
—
Div Yield, %
—
Shrs. gr., 5y
32.57%
Rev. gr., 5y
-52.14%
Revenues
1k
-40.58%
Net income
-657k
L-78.93%
CFO
-473k
L+30.12%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
TALi Digital Limited is an Australian digital health firm dedicated to improving cognitive function and behavior through its diagnostic and therapeutic offerings. The company provides TALi DETECT, an evidence-based digital screening program lasting 20-30 minutes, which utilizes cognitive assessments to gauge a child's attention skills relative to their peers. Complementing this is TALi TRAIN, a digital cognitive training solution designed to enhance selective attention and numeracy, and in certain cases, alleviate inattentive and hyperactive behaviors in children. The company maintains a significant licensing agreement with Akili Interactive Labs, Inc. for pediatric cognitive products. Founded in 2004, the enterprise, headquartered in Camberwell, was formerly known as Novita Healthcare Limited until its name change in December 2019.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||